Arizona providers face a continuous stream of payer policy changes: coverage edits, prior authorization expansions, billing code revisions, and Medicaid reimbursement updates that affect day-to-day practice operations. This page surfaces every tracked policy change that explicitly names Arizona, so your billing and compliance teams can act before the effective date, not after a claim denial.
Effective January 1, 2027, UnitedHealthcare is adding prior authorization requirements for 11 HCPCS oncology medication codes when administered in outpatient settings for cancer treatment. These codes include busulfan, leucovorin calcium, luspatercept, dexrazoxane, dinutuximab, octreotide, triptorelin, omidubicel, zoledronic acid, and cyclosporine. This change applies across commercial, Medicare Advantage, Medicaid, and Individual Exchange plans.
Effective January 1, 2027, Ambetter from Arizona Complete Health will discontinue coverage for 45 HCPCS H codes (primarily behavioral health and social services codes) while adding coverage for H0006. Billing teams must identify all claims using the discontinued codes and implement alternative billing strategies to avoid claim denials.
Blue Cross Blue Shield of Arizona's new Evidence-Based Criteria for collagen dressings and collagen-based wound fillers (effective 01/01/27) define when these products are medically necessary: a full-thickness wound (e.g., stage 3 or 4), light-to-moderate exudate, or a stalled wound, prescribed by a physician or wound specialist after evaluation, with documented location, type, stage, size, appropriate dressing size, and change frequency if more frequent than standard. Claims for these products (HCPCS A6010, A6011, A6021-A6024) that do not meet these criteria, or that involve heavy exudate, third-degree burns, or active vasculitis, will be considered not medically necessary.
AHCCCS has launched KeepMyAHCCCS.com, a resource website to help approximately 417,000 Arizona Medicaid members understand and prepare for new federal work requirements taking effect January 1, 2027. This is an informational/educational initiative with no direct impact on billing codes, prior authorization, or reimbursement processes, but practices should be aware that members may face eligibility changes.
Blue Cross Blue Shield of Arizona has issued a new Evidence-Based Criteria policy (effective 11/01/26) that classifies 62 specific CPT and HCPCS codes as experimental or investigational services and therefore non-covered. This policy applies broadly across multiple specialties and requires billing teams to deny claims for these codes unless members have explicit coverage for experimental services in their benefit plans.
UnitedHealthcare Community Plans is expanding prior authorization reductions across six states, eliminating prior auth requirements for select CPT codes effective November 1, 2026 (Arizona, New Mexico, New York, Ohio) and December 1, 2026 (Missouri, Washington). Billing teams must identify which codes are impacted in their state and remove prior authorization requirements from workflows for affected procedures.
This historical AHCCCS Fee-for-Service Claims Clues newsletter (issued 2026-10-01, first detected 2026-11-05) notes that new FFS rates applied to dates of service on and after October 1, 2026, and that providers with authorized BHRF and IOP services continuing into the new rate period must submit a new prior authorization case with a begin date of October 1, 2026, with supporting documentation. It also restates claims and attachment rules: submit the claim first with a unique PWK number, upload documents via the EDI Solutions portal, do not bill the same CPT/HCPCS on multiple lines for the same date of service, and submit replacement claims within the stated timely filing windows.
This is a comprehensive Medicare Advantage coverage policy for molecular biomarker tests used in prostate cancer risk stratification (effective 10/1/2026). The policy establishes coverage criteria for tests like ArteraAI, EpiSwitch, IsoPSA, MyProstateScore 2.0, ProMark, and ProsTAV, with coverage determinations based on MAC-specific LCDs/LCAs that vary by geographic jurisdiction. Billing teams must identify the correct MAC jurisdiction and apply the corresponding LCD requirements for each test ordered.
This is a comprehensive Medicare Advantage bariatric surgery coverage policy (HUM-1020-005) effective October 1, 2026, that outlines coverage determinations, limitations, and coding requirements for various bariatric procedures. The policy applies Humana's Medicare Advantage coverage standards and references applicable MAC Local Coverage Determinations by geographic jurisdiction, with specific rules varying by state and MAC region.
This is a revised Medicare Advantage medical coverage policy for spinal fusion surgery (effective 09/01/2026) that consolidates coverage determination, limitations, coding information, and evidence summaries for cervical, lumbar, and thoracic spinal fusion procedures. The policy references multiple MAC-specific Local Coverage Determinations (LCDs) across geographic jurisdictions and outlines covered procedures including traditional fusion, minimally invasive approaches (DLIF, XLIF, MITLIF), sacroiliac joint fusion, and interlaminar fusion techniques. Billing teams must align claims submission with the applicable MAC LCD based on patient location and ensure procedures meet specific medical necessity criteria outlined in the referenced determinations.
This is a comprehensive Medicare Advantage coverage policy for Benign Prostatic Hyperplasia treatments effective September 1, 2026. The policy outlines coverage determinations for multiple BPH treatment modalities including surgical procedures (TURP, prostatectomy, laser therapies), temporary implanted devices, stents, and diagnostic testing. The policy references multiple MAC-specific Local Coverage Determinations (LCDs) that vary by geographic jurisdiction, requiring billing teams to verify applicable coverage rules based on patient location.
Humana Medicare Advantage has revised its Ambulatory Cardiac Monitoring Devices policy effective September 1, 2026. The policy provides updated coverage guidance for various cardiac monitoring technologies (Holter monitors, patch recorders, external loop monitors, implantable loop recorders, and mobile cardiac outpatient telemetry) with MAC-specific coverage determinations by geographic jurisdiction. The policy document appears incomplete but establishes that medical necessity determinations will follow applicable NCDs and LCDs based on the member's jurisdiction.
Effective September 1, 2026, claims submitted by fee-for-service providers that include a referring, ordering, attending or prescribing provider who is not registered with AHCCCS will be denied, and those providers must register or be identified as exception non-registerable providers. Group behavioral health services must have the HQ modifier appended to the service code, and omitting it results in inaccurate billing and may directly affect reimbursement. Intensive Outpatient Program prior authorization requests must use Event Type OP until AHCCCS adds IOP as a selectable event type.
This policy, effective 09/01/26, requires site-of-service review and, when applicable, prior authorization for specified outpatient procedures performed in a hospital outpatient setting, and the lowest appropriate level of care capable of safely performing the procedure is preferred in the absence of a clinical contraindication. A hospital outpatient facility instead of an ambulatory surgery center for a planned outpatient procedure is medically necessary with documentation of ANY of 38 listed criteria, including age 18 years or younger, prolonged surgery (>3 hours), morbid obesity (BMI 40 or higher), pregnancy, ASA Physical Status classification III or higher, moderate to severe obstructive sleep apnea, or uncontrolled epilepsy. The policy covers specified musculoskeletal, digestive and urinary system CPT codes.
Already effective August 24, 2026, AHCCCS prepayment reviews claims for H2038 (skills training and development, per diem) billed without a group modifier, and supporting medical documentation must be submitted with the initial claim and every replacement claim. Already effective September 4, 2026, the Alivia analytics tool reviews NEMT trip tickets and a set of claim edits, and claims containing the listed errors will be denied. Already effective September 1, 2026, claims submitted by fee-for-service providers that include a referring, ordering, attending or prescribing provider who is not registered with AHCCCS will be denied.
This is a comprehensive Medicare Advantage coverage policy for neuroablative techniques used to treat chronic pain, effective 08/06/2026. The policy defines coverage criteria, eligible procedures (including radiofrequency ablation, cryoablation, chemical neurolysis, and specialized devices like Intracept), and references MAC-specific LCDs and billing codes by geographic jurisdiction. Billing teams must verify applicable MAC guidelines for their state and ensure claims comply with local coverage determinations.
This is a comprehensive Medicare Advantage policy on neuroablative techniques for chronic pain management, effective 08/06/2026. The policy defines covered denervation procedures (radiofrequency ablation, cryoablation, facet denervation, basivertebral nerve ablation, and others) and references MAC-specific LCDs and NCDs that vary by geographic jurisdiction. Billing teams must verify applicable MAC requirements for their region before processing claims for these procedures.
This is a comprehensive Medicare Advantage policy on genetic testing for hereditary cancer syndromes, effective August 3, 2026. The policy establishes coverage guidelines for germline genetic testing across multiple cancer types (melanoma, gastric cancer, neuroendocrine tumors, renal cell carcinoma, and others) and references specific MAC-based Local Coverage Determinations (LCDs) that vary by geographic jurisdiction. Billing teams must verify applicable MAC jurisdiction and LCD requirements before processing claims.
Humana Medicare Advantage has revised its breast reconstruction coverage policy (effective 08/03/2026) to clarify medical necessity criteria for reconstruction procedures following mastectomy, trauma, or congenital abnormalities. The policy applies MAC-specific Local Coverage Determinations (LCDs) by geographic jurisdiction and establishes criteria for determining coverage of implant removal, reduction mammaplasty, and related procedures. Billing teams must identify the appropriate MAC jurisdiction for each claim and apply the correct LCD requirements.
Humana Medicare Advantage has updated its Breast Excision and Mastectomy policy (HUM-1254-009) effective 08/03/2026. This revised policy clarifies coverage criteria for breast lesion excisions (CPT 19120, 19125), partial mastectomies (CPT 19301, 19302), and gynecomastia mastectomy (CPT 19300) across multiple MAC jurisdictions. The policy establishes specific medical necessity criteria based on biopsy results, lesion characteristics, and anatomical considerations, and applies jurisdiction-specific Local Coverage Determinations (LCDs) for Medicare Administrative Contractors.
This is a comprehensive Medicare Advantage policy for Benign Prostatic Hyperplasia (BPH) treatments that became effective on August 3, 2026. The policy outlines coverage for multiple surgical and minimally invasive treatment modalities including TURP, laser therapies, temporary implanted devices, and stents, with specific coverage determinations varying by MAC jurisdiction. Billing teams must verify applicable MAC-specific LCDs and NCDs by geographic location before processing BPH treatment claims.
AHCCCS has issued July 2026 claims guidance clarifying FQHC/RHC reimbursement for case management (T1016), best practices for prior authorization timing, claim submission deadlines, correcting a system denial error (L243.1), and eliminating unnecessary service descriptions in behavioral health claims. Critical changes include guidance that claims must be submitted within 6 months even if prior authorization is pending, and providers must not include service descriptions when reporting participating provider details.
This is a revised Medicare Advantage policy for breast imaging (effective 07/01/2026) that establishes coverage criteria for mammography, digital breast tomosynthesis, breast MRI, and ultrasound. The policy clarifies medical necessity requirements and references applicable Local Coverage Determinations (LCDs) by MAC jurisdiction. Billing teams must verify which MAC jurisdiction applies to their geographic location to determine specific coverage rules.
AHCCCS (Arizona's Medicaid program) has launched the Alivia 360 analytics tool (effective June 29, 2026) to improve claims accuracy and strengthen program integrity through enhanced claim review processes. A new 'Access to Care/Eligibility' form is now live on the AHCCCS Solutions Center. New claim edits are being added monthly, and providers will receive detailed emails about these edits. Additionally, AHCCCS is launching a statewide H.R. 1 community awareness campaign to help members understand work/community engagement requirements and eligibility redetermination processes.
Ambetter Health is reminding providers to verify member eligibility using paid-through dates before service delivery, as Marketplace members facing premium payment issues may enter grace periods or have coverage retroactively terminated. Providers must check member status, premium paid-through date, and claims paid-through date to avoid claim denials and reduce administrative burden.
Effective June 15, 2026, Ambetter from Arizona Complete Health is updating IONM billing requirements for Marketplace plans. Only CMS-recognized payable code 95940/G0453 is covered; code 95941 is non-covered. Billing must comply with strict CMS criteria including exclusive patient attention, maximum 4 units per 60 minutes, appropriate place of service codes, and cannot be billed by surgeon or anesthesia provider.
AHCCCS is launching a new Customer Support System (CSS) on May 4, 2026, which will become the primary way to submit provider service requests including claims, billing, and general inquiries. A new Live-in Caregiver report is also available in the AHCCCS EVV Aggregator for tracking caregiver relationships and compliance.
Effective April 1, 2026, Ambetter Health will no longer cover HCPCS add-on codes G2211 (complexity add-on for established patient relationships) and G2212 (prolonged E/M services). Billing teams must stop submitting these codes for Ambetter claims and use only primary CPT E/M codes (99202–99215) instead.
Molina Care Connections expands telehealth and in-person nurse practitioner services across 22 states with open scheduling for preventive care and chronic condition management. Developmental screening requirements for children ages 1-3 now mandate use of standardized global screening tools (CPT 96110) with specific documentation; domain-specific tools (M-CHAT, ASQ:SE) are no longer billable for this measure. Utilization management criteria and processes remain unchanged but are clarified for provider reference.
UnitedHealthcare is expanding prior authorization requirements for physical therapy, speech therapy, occupational therapy, and chiropractic services to Medicare Advantage members in Arizona and California starting February 1, 2026. Prior auth requests can be submitted starting January 1, 2026, and while the first 6 visits within 8 weeks are covered without clinical review, a prior authorization request must still be submitted.
UnitedHealthcare Community Plan (Medicaid) now requires enhanced medical documentation for prior authorization of total hip and knee joint replacement surgeries (CPT 27447, 27130, 27132) when performed for osteoarthritis. New requirements include detailed imaging reports with specific findings and provider specialties who interpreted images, rolling out across multiple states with different effective dates.
Ambetter from Arizona Complete Health is discontinuing coverage under HCPCS bundled code 80050 effective 10/01/2025. The four component tests (Comprehensive Metabolic Panel, Complete Blood Count, and Thyroid Stimulating Hormone) must now be billed individually using their respective codes. All submissions of bundled code 80050 after 09/30/2025 will receive automatic denials with explanation code 46.
Effective September 15, 2025, HCPCS codes S5000 (generic prescription drugs) and S5001 (brand name prescription drugs) will require prior authorization when billed charges exceed $500. Billing teams must implement system-level controls to capture these codes and flag high-dollar claims for authorization before submission.
Effective August 29, 2025, Ambetter from Arizona Complete Health now requires prior authorization for HCPCS code H0019 (behavioral health; long-term residential per diem). Providers billing this code must obtain prior authorization before submitting claims to avoid denials.
This is an Aetna September 2025 newsletter announcing multiple upcoming policy changes including new claim edits effective December 1, 2025, changes to the National Precertification List effective January 1, 2026, and updates to commercial drug lists effective January 1, 2026. The newsletter also highlights biosimilar prescribing guidance, behavioral health updates including ABA medical necessity guide changes, and state-specific regulatory updates across 19 states.
Arizona AHCCCS is in the final month of unwinding continuous Medicaid enrollment that was in place during the COVID-19 Public Health Emergency. Members will transition back to regular Medicaid renewal processes. Billing teams must prepare for increased eligibility verification and potential coverage gaps as continuous enrollment ends.
AHCCCS has paused all member transition activities for the ALTCS-EPD program that were scheduled to begin October 1, 2024, pending review of an Administrative Law Judge decision that found procurement process flaws. The agency has 30 days from the ALJ decision (August 9th) to accept, reject, or modify the recommendation, which may result in contract cancellation and a new procurement process.
AHCCCS released an updated Covered Behavioral Health Services Guide with significant revisions to multiple sections based on stakeholder feedback. The billing team must obtain the complete updated guide to identify specific coverage changes, billing code impacts, and documentation requirements for behavioral health services in Arizona.
UnitedHealthcare is reminding providers that multigene RNA panel testing for hereditary cancer is considered unproven and will be denied. Only DNA-only hereditary cancer panels and single-gene RNA testing remain covered under applicable medical policy and prior authorization requirements.
Devoted Health released Q3 2024 provider updates requiring immediate attention to Star measure performance (readmission prevention, ER follow-up, transitions of care), annual SNP Model of Care training compliance, risk adjustment documentation accuracy for cancer/obesity/diabetes, and NPI data validation. Arizona providers must now refer MSK cases to HOPCo Specialty Care Network via new fax process.
Healthcare providers enrolled in the Arizona Vaccines for Children (VFC) program must renew their enrollment by August 31, 2026. Failure to renew will result in program inactivation for non-compliance, and patients under age 18 may be removed from the provider's patient panel, disrupting vaccine administration services.
AHCCCS (Arizona Medicaid) requires all claims to list the correct rendering provider who actually provided the care. Billing with another provider's ID number is prohibited except in approved locum tenens situations, and hospitals/clinics cannot bill using facility NPI numbers for physician/mid-level practitioner services.
AHCCCS implemented Medically Unlikely Edits (MUEs) that will deny entire claim lines when units of service exceed maximum allowable limits for specific procedures. Claims exceeding MUE limits will be denied with edit code L207 and must be rebilled with correct units.
AHCCCS (Arizona Medicaid) is requiring all providers to complete re-registration in their new Provider Enrollment Portal (APEP) before the COVID-19 public health emergency ends. Providers who don't complete re-registration will need to undergo full re-validation or face enrollment termination.
AHCCCS (Arizona Medicaid) will resume eligibility reviews after pandemic protections end, potentially disenrolling approximately 500,000 members who no longer meet requirements. Billing teams should prepare for patient insurance verification changes and potential coverage gaps.
AHCCCS (Arizona Medicaid) is preparing to end the Public Health Emergency disenrollment suspensions that have kept members enrolled since March 2020. When the PHE ends, AHCCCS will resume standard eligibility redeterminations and disenroll members who no longer qualify, potentially affecting patient coverage and billing.
AHCCCS (Arizona Medicaid) is terminating thousands of providers who failed to complete mandatory revalidation during the November 2022 - August 2023 period. Providers who missed this deadline are losing their Medicaid billing privileges and access to the AHCCCS portal for claims submission.
AHCCCS has suspended payments to over 100 Medicaid providers due to fraudulent billing practices in behavioral health services, including billing for excessive hours, services not provided, and ghost billing. The agency has implemented new system-wide controls including elevated risk categories for behavioral health providers, new reporting flags, billing thresholds, and prepayment reviews to prevent future fraud.
CGS Administrators' LCD L39284 (Prostate Cancer Detection with IsoPSA®), revised in R4 dated 11/05/2026, provides limited coverage for the IsoPSA® blood test for men 50 and older with a confirmed PSA above 4 and up to 25 ng/mL and no relative contraindication to biopsy such as less than a 10-year life expectancy. The source states its annual review made no changes, and the stated effective date of 11/5/2026 is already before the analysis date of 2026-11-06, so these criteria are already in effect and should be checked for current applicability. The practice should align IsoPSA® orders and claims with these indications and the confirmed-PSA requirement.
Humana Medicare Advantage revised its neuroablative techniques for chronic pain policy effective 11/01/2026. The policy update describes coverage criteria, limitations, and coding guidance for multiple denervation procedures (radiofrequency ablation, cryotherapy, facet denervation, basivertebral nerve ablation, and other neuroablative techniques). The practice must verify applicable MAC LCDs by geographic jurisdiction, obtain prior authorization as required, and ensure claims are submitted with correct coding and documentation.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.